The company is solving some of the most advanced research problems arising out of an unprecedented application of recent advances in AI to the medical domain. From crunching through microscopy images of blood to quantify normal and abnormal blood cells, to tracking sperm cells in microscopy videos, to localizing pathologies in retinal scan images, we are at the bleeding edge of things. Research in core AI, computer vision and extreme platform engineering are an integral part of our journey.
Its solutions will allow labs and hospitals to scale by implementing a hub and spoke model where the medical experts can operate from hub and devices can be installed in spokes. The solution will be available at a very affordable price and will enable labs to adopt technology without changing the hardware. It will improve the efficiency of medical experts by automating painful and fatigue driven visual medical analysis process.
says, “Our goal is to develop intelligent, scalable and affordable disease screening solutions which can empower medical experts and facilitate quality healthcare delivery to the masses. Our initial focus is on the solutions for the screening tests so that we can positively impact a larger population not only in India but globally,” said Rohit Kumar Pandey, co-founder and chief executive officer, SigTuple.
“When we evaluate opportunities, one of the most important things we look at is the fit between the founders and the business opportunity. In this case, the AI/ML part of the business is the core and the background of the founders was a great fit. We believe that they have a well thought through approach to the problem and hence we decided to back them,” said Barath Shankar Subramanian, Accel Partners
The platform also exposes an interface for the medical experts to get feedback and annotations which enables continuous learning with new and changing visual medical data.
Sigtuple raises, series a funding